Saroja Pharma Industries India Limited (NSE: SAROJA)

Market Cap	233.99M
Revenue (ttm)	406.69M
Net Income (ttm)	8.78M
Shares Out	4.02M
EPS (ttm)	2.49
PE Ratio	23.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	33.10 - 82.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About SAROJA

Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, and Europe. The company’s specialty chemicals and its intermediates are used in various applications, including pharma, agro, chemicals, performance chemicals, resins, paint, food, adhesive, and various other industries. Its products are also used in human and veterinary medicines. The company was incorporated in 2019 and is based in Mumbai, India.

• Industry: Chemicals And Allied Products
• Founded: 2019
• Employees: 13
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAROJA

Financial Performance

In 2023, SAROJA's revenue was 406.69 million, a decrease of -18.97% compared to the previous year's 501.93 million. Earnings were 8.78 million, a decrease of -17.19%.